Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA)

Maria Jedrzejowska, Wojciech Wiszniewski, Janusz Zimowski, Anna Kostera-Pruszczyk, Barbara Ryniewicz, Jerzy Bal, Jacek Zaremba, Tadeusz Mazurczak, Irena Hausmanowa-Petrusewicz

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background and purpose: Proximal spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations of the SMN1 gene. The most frequent mutation is biallelic deletion of exon 7 of the SMN1 gene. A small percentage of SMA patients present compound heterozygosity with a point mutation on one allele and deletion on the other. In the remaining cases the disease is unlikely to be related to SMN1 defects. The aim of our study was to estimate the frequency of the common biallelic exon 7 SMN1 deletion in our Polish SMA cohort and implement a test for assessing a molecular defect at the SMN1 locus versus defects in the other genes. Material and methods: The molecular analysis was performed in a group of 269 patients fulfilling diagnostic criteria of the International SMA Consortium. The common SMN1 exon 7 deletion was tested by a standard PCR analysis. Patients lacking the common mutation were subsequently analyzed for a number of SMN1 alleles with a quantitative test based on real-time PCR. Results: The frequency of homozygous loss of exon 7 in the SMN1 gene was 96.6% (260/269) in our Polish SMA cohort. In 5 of 9 non-deleted patients the real-time PCR analysis showed a decreased number of SMN1 copies. We anticipate that the non-deleted allele carries a second mutation in SMN1 which may contribute to the pathogenesis of SMA. We have also identified 4 patients (1.5%) with SMA carrying two SMN1 alleles without the exon 7 deletion. Conclusions: The molecular analysis of the biallelic exon 7 of the SMN1 deletion is a standard and reliable test in cases of SMA. Introduction of a quantitative test based on "real-time PCR" further enhances the diagnostic potential by increasing the detection rate of cases likely to be caused by point mutation of the SMN1 gene.

Original languageEnglish (US)
Pages (from-to)89-94
Number of pages6
JournalNeurologia i Neurochirurgia Polska
Volume39
Issue number2
StatePublished - 2005
Externally publishedYes

Fingerprint

Spinal Muscular Atrophy
Exons
Alleles
Real-Time Polymerase Chain Reaction
Mutation
Genes
Point Mutation
Polymerase Chain Reaction

Keywords

  • Deletion
  • Real-time PCR
  • SMA
  • SMN1 gene

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Jedrzejowska, M., Wiszniewski, W., Zimowski, J., Kostera-Pruszczyk, A., Ryniewicz, B., Bal, J., ... Hausmanowa-Petrusewicz, I. (2005). Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA). Neurologia i Neurochirurgia Polska, 39(2), 89-94.

Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA). / Jedrzejowska, Maria; Wiszniewski, Wojciech; Zimowski, Janusz; Kostera-Pruszczyk, Anna; Ryniewicz, Barbara; Bal, Jerzy; Zaremba, Jacek; Mazurczak, Tadeusz; Hausmanowa-Petrusewicz, Irena.

In: Neurologia i Neurochirurgia Polska, Vol. 39, No. 2, 2005, p. 89-94.

Research output: Contribution to journalArticle

Jedrzejowska, M, Wiszniewski, W, Zimowski, J, Kostera-Pruszczyk, A, Ryniewicz, B, Bal, J, Zaremba, J, Mazurczak, T & Hausmanowa-Petrusewicz, I 2005, 'Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA)', Neurologia i Neurochirurgia Polska, vol. 39, no. 2, pp. 89-94.
Jedrzejowska, Maria ; Wiszniewski, Wojciech ; Zimowski, Janusz ; Kostera-Pruszczyk, Anna ; Ryniewicz, Barbara ; Bal, Jerzy ; Zaremba, Jacek ; Mazurczak, Tadeusz ; Hausmanowa-Petrusewicz, Irena. / Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA). In: Neurologia i Neurochirurgia Polska. 2005 ; Vol. 39, No. 2. pp. 89-94.
@article{21aa262d377148879477fe34625cf5de,
title = "Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA)",
abstract = "Background and purpose: Proximal spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations of the SMN1 gene. The most frequent mutation is biallelic deletion of exon 7 of the SMN1 gene. A small percentage of SMA patients present compound heterozygosity with a point mutation on one allele and deletion on the other. In the remaining cases the disease is unlikely to be related to SMN1 defects. The aim of our study was to estimate the frequency of the common biallelic exon 7 SMN1 deletion in our Polish SMA cohort and implement a test for assessing a molecular defect at the SMN1 locus versus defects in the other genes. Material and methods: The molecular analysis was performed in a group of 269 patients fulfilling diagnostic criteria of the International SMA Consortium. The common SMN1 exon 7 deletion was tested by a standard PCR analysis. Patients lacking the common mutation were subsequently analyzed for a number of SMN1 alleles with a quantitative test based on real-time PCR. Results: The frequency of homozygous loss of exon 7 in the SMN1 gene was 96.6{\%} (260/269) in our Polish SMA cohort. In 5 of 9 non-deleted patients the real-time PCR analysis showed a decreased number of SMN1 copies. We anticipate that the non-deleted allele carries a second mutation in SMN1 which may contribute to the pathogenesis of SMA. We have also identified 4 patients (1.5{\%}) with SMA carrying two SMN1 alleles without the exon 7 deletion. Conclusions: The molecular analysis of the biallelic exon 7 of the SMN1 deletion is a standard and reliable test in cases of SMA. Introduction of a quantitative test based on {"}real-time PCR{"} further enhances the diagnostic potential by increasing the detection rate of cases likely to be caused by point mutation of the SMN1 gene.",
keywords = "Deletion, Real-time PCR, SMA, SMN1 gene",
author = "Maria Jedrzejowska and Wojciech Wiszniewski and Janusz Zimowski and Anna Kostera-Pruszczyk and Barbara Ryniewicz and Jerzy Bal and Jacek Zaremba and Tadeusz Mazurczak and Irena Hausmanowa-Petrusewicz",
year = "2005",
language = "English (US)",
volume = "39",
pages = "89--94",
journal = "Neurologia i Neurochirurgia Polska",
issn = "0028-3843",
publisher = "Termedia Publishing House Ltd.",
number = "2",

}

TY - JOUR

T1 - Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA)

AU - Jedrzejowska, Maria

AU - Wiszniewski, Wojciech

AU - Zimowski, Janusz

AU - Kostera-Pruszczyk, Anna

AU - Ryniewicz, Barbara

AU - Bal, Jerzy

AU - Zaremba, Jacek

AU - Mazurczak, Tadeusz

AU - Hausmanowa-Petrusewicz, Irena

PY - 2005

Y1 - 2005

N2 - Background and purpose: Proximal spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations of the SMN1 gene. The most frequent mutation is biallelic deletion of exon 7 of the SMN1 gene. A small percentage of SMA patients present compound heterozygosity with a point mutation on one allele and deletion on the other. In the remaining cases the disease is unlikely to be related to SMN1 defects. The aim of our study was to estimate the frequency of the common biallelic exon 7 SMN1 deletion in our Polish SMA cohort and implement a test for assessing a molecular defect at the SMN1 locus versus defects in the other genes. Material and methods: The molecular analysis was performed in a group of 269 patients fulfilling diagnostic criteria of the International SMA Consortium. The common SMN1 exon 7 deletion was tested by a standard PCR analysis. Patients lacking the common mutation were subsequently analyzed for a number of SMN1 alleles with a quantitative test based on real-time PCR. Results: The frequency of homozygous loss of exon 7 in the SMN1 gene was 96.6% (260/269) in our Polish SMA cohort. In 5 of 9 non-deleted patients the real-time PCR analysis showed a decreased number of SMN1 copies. We anticipate that the non-deleted allele carries a second mutation in SMN1 which may contribute to the pathogenesis of SMA. We have also identified 4 patients (1.5%) with SMA carrying two SMN1 alleles without the exon 7 deletion. Conclusions: The molecular analysis of the biallelic exon 7 of the SMN1 deletion is a standard and reliable test in cases of SMA. Introduction of a quantitative test based on "real-time PCR" further enhances the diagnostic potential by increasing the detection rate of cases likely to be caused by point mutation of the SMN1 gene.

AB - Background and purpose: Proximal spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations of the SMN1 gene. The most frequent mutation is biallelic deletion of exon 7 of the SMN1 gene. A small percentage of SMA patients present compound heterozygosity with a point mutation on one allele and deletion on the other. In the remaining cases the disease is unlikely to be related to SMN1 defects. The aim of our study was to estimate the frequency of the common biallelic exon 7 SMN1 deletion in our Polish SMA cohort and implement a test for assessing a molecular defect at the SMN1 locus versus defects in the other genes. Material and methods: The molecular analysis was performed in a group of 269 patients fulfilling diagnostic criteria of the International SMA Consortium. The common SMN1 exon 7 deletion was tested by a standard PCR analysis. Patients lacking the common mutation were subsequently analyzed for a number of SMN1 alleles with a quantitative test based on real-time PCR. Results: The frequency of homozygous loss of exon 7 in the SMN1 gene was 96.6% (260/269) in our Polish SMA cohort. In 5 of 9 non-deleted patients the real-time PCR analysis showed a decreased number of SMN1 copies. We anticipate that the non-deleted allele carries a second mutation in SMN1 which may contribute to the pathogenesis of SMA. We have also identified 4 patients (1.5%) with SMA carrying two SMN1 alleles without the exon 7 deletion. Conclusions: The molecular analysis of the biallelic exon 7 of the SMN1 deletion is a standard and reliable test in cases of SMA. Introduction of a quantitative test based on "real-time PCR" further enhances the diagnostic potential by increasing the detection rate of cases likely to be caused by point mutation of the SMN1 gene.

KW - Deletion

KW - Real-time PCR

KW - SMA

KW - SMN1 gene

UR - http://www.scopus.com/inward/record.url?scp=18644379648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18644379648&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 89

EP - 94

JO - Neurologia i Neurochirurgia Polska

JF - Neurologia i Neurochirurgia Polska

SN - 0028-3843

IS - 2

ER -